SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?


To: Jorj X Mckie who wrote (21308)1/14/2003 3:15:55 PM
From: tuck  Read Replies (1) | Respond to of 57110
 
LYNX is a struggling genomics company. Might be worth a check. They face delisting, but appear to be trading under cash (not sure of converts or other debt, though). Of, course, they only had about $13 million in the latest quarter, and they surely have less now. They are in a crowded market, don't know how competitive their products might be. If burn is low, they could be a munch candidate for the cash alone.

Cheers, Tuck